ACM
MXCT icon

Aster Capital Management’s MaxCyte MXCT Stock Holding History

Aster Capital Management’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$201K Buy
+163,270
New +$163K 0.04% 416

Other funds holding MXCT

CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $201M AUM 10.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $481M AUM 73.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BFM
Brooklands Fund Management London, United Kingdom $128M AUM
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return

Aster Capital Management's MXCT Position: Q2 2026 in Review

Aster Capital Management opened a new position in MaxCyte (MXCT) in Q2 2026: 163,270 shares worth $201K. The stake represents 0.04% of the portfolio and ranks #416 among its holdings.

123 funds tracked by Wall St. Rank hold MXCT as of Q2 2026.

  • Aster Capital Management held 163,270 shares of MaxCyte worth $201K as of Q2 2026.
  • MaxCyte was a new Aster Capital Management position in Q2 2026.
  • MaxCyte made up 0.04% of Aster Capital Management's portfolio in Q2 2026, its #416 holding.
  • 123 funds tracked by Wall St. Rank held MaxCyte as of Q2 2026.

Based on Aster Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.